Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion type Assertion NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_head.
- NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion wasGeneratedBy ECO_0000203 NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_provenance.
- NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion wasDerivedFrom befree-20140225 NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_provenance.
- NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion SIO_000772 17559739 NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_provenance.
- NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion evidence source_evidence_literature NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_provenance.
- NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_assertion description "[The proportional cost of treating hepatitis C when using epoetin to treat RIA is significant in genotype 2 or 3 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169998.RAey5HHdBp1QB1cMsT_EegkqEct5yb5axLKTuoCwqVNOw130_provenance.